Adverse events: number of people experiencing adverse events (all cause or COPD‐related), serious adverse events, mortality · COPD
Multi‐component intervention showed no clear difference in adverse events: number of people experiencing adverse events (all… compared with control (low certainty).
1 finding from 1 review
Adherence to pharmacotherapy: number of people achieving adherence to medication · COPD
Multi‐component intervention may leads to higher adherence to pharmacotherapy: number of people achieving adherence… compared with control (low certainty).
1 finding from 1 review
Quality of life: SGRQ total, SF CRDQ total, CAT total · COPD
1 finding from 1 review
Hospital admissions · COPD
Multi‐component intervention may leads to lower hospital service utilisation: number of people admitted to hospital… compared with control (low certainty).
1 finding from 1 review
Exacerbations: number of people experiencing moderate or severe exacerbations · COPD
It is very uncertain whether multi‐component intervention changes exacerbations: number of people experiencing moderate or severe… compared with control (very low certainty).
1 finding from 1 review
Adherence to pharmacotherapy: number of people completing treatment · COPD
Single component intervention showed no clear difference in adherence to pharmacotherapy: number of people completing treatment compared with control (low certainty).
1 finding from 1 review
Quality of life: SGRQ total or CCQ · COPD
1 finding from 1 review
Hospital admissions · COPD
It is very uncertain whether single component intervention changes hospital service utilisation: number of people admitted to hospital… compared with control (very low certainty).
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · COPD
It is very uncertain whether single component intervention changes exacerbations: number of people experiencing exacerbations compared with control (very low certainty).
1 finding from 1 review
Adverse events: number of people experiencing adverse events (all cause or COPD‐related), serious adverse events, mortality · COPD
It is very uncertain whether single component intervention changes adverse events: number of people experiencing adverse events (all… compared with control (very low certainty).
1 finding from 1 review
Exacerbations: number of people experiencing moderate or severe exacerbations · treatment for asthma in adults and children with asthma and GORD
Medical or surgical intervention, or both, for gastro‐oesophageal… showed no clear difference in number of participants with moderate/severe acute exacerbations… compared with nil intervention, delayed intervention control, or placebo (low certainty).
1 finding from 1 review
Lung function: FEV1 mL (change from baseline) · treatment for asthma in adults and children with asthma and GORD
1 finding from 1 review
Use of "rescue" medications and emergency action plans: B2 use puffs per day Duration of treatment: range 14 weeks to 24 weeks · treatment for asthma in adults and children with asthma and GORD
1 finding from 1 review
Change in quality of life · treatment for asthma in adults and children with asthma and GORD
1 finding from 1 review
Healthcare utilisation ‐ not measured · treatment for asthma in adults and children with asthma and GORD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found